SLU-PP-332 (250mcg) × 60 Tablets

This single-compound research tablet contains SLU-PP-332, a small molecule investigated for its potential to modulate the AMPK signaling pathway and influence energy metabolism. Designed for researchers exploring mechanisms of endurance enhancement, mitochondrial activity, and metabolic regulation, SLU-PP-332 provides a reliable format for controlled preclinical investigation of cellular energy pathways.

Composition (Per Tablet):
SLU-PP-332 – 250mcg
60 tablets per bottle

Key Characteristics:

• SLU-PP-332: AMPK pathway modulator studied in models of metabolic regulation and endurance adaptation

• Investigated for its role in mitochondrial biogenesis and energy utilization

• Oral tablet format designed for stability and consistent compound delivery

• Precise dosing suited for reproducible metabolic research studies

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.